Ferrante Karen Jean — SEC Form 4 filings
SEC reporting owner CIK 1598502. 17 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-04-02 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | Director | 13 | — | — | 13 |
| MACROGENICS INC (MGNX) | Director | 4 | — | — | 12 |
Form 4 filings — Ferrante Karen Jean
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 627 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | MACROGENICS INC (MGNX) | Option exercise (M): 3,750 · Option exercise (M): 3,750 (derivative) @ $0 · Grant/award (A): 3,750 (derivative) @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 686 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 643 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 1,642 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 3,314 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | MACROGENICS INC (MGNX) | Option exercise (M): 6,500 · Option exercise (M): 6,500 (derivative) @ $0 · Grant/award (A): 3,750 (derivative) @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 3,788 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,785 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,034 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 2,462 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | MACROGENICS INC (MGNX) | Grant/award (A): 6,500 (derivative) @ $0 · Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | MACROGENICS INC (MGNX) | Option exercise (M): 4,500 @ $0 · Option exercise (M): 4,500 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 3,213 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1598502 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →